Cognitive dysfunction in corticobasal degeneration
ABSTRACT Corticobasal degeneration (CBD) was originally described as a distinct clinicopathological entity in 1967. Since then, different phenotypic presentations have emerged as possible manifestations of CBD histopathological findings. In addition, pathophysiological findings and the molecular bas...
Main Authors: | Laís Machado de Oliveira, Igor Barcellos, Hélio A.G. Teive, Renato Puppi Munhoz |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800570&lng=en&tlng=en |
Similar Items
-
Corticobasal degeneration and corticobasal syndrome: A review
by: Vasilios C. Constantinides, et al.
Published: (2019-01-01) -
Pharmacological interventions in corticobasal degeneration: a review
by: Leonardo Caixeta, et al.
Published: (2020-09-01) -
Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01) -
Corticobasal degeneration presented as rapidly progressive dementia
by: Sunil Suthar, et al.
Published: (2015-01-01) -
Levodopa-responsive depression associated with corticobasal degeneration: a case report
by: Tarakita N, et al.
Published: (2017-04-01)